Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized multicenter phase 3 trial of homeopathic dopamine + serotoninum muriaticum in children with ADHD
2010-020810-27Phase 3
- Sponsor
- Boiron
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dopamine and serotoninum muriaticum in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Boiron.
02
Drugs
dopamineserotoninum muriaticum
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2010-020810-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020810-27.